Literature DB >> 24297792

Carbohydrate feeding dissociates the postprandial FGF19 response from circulating bile acid levels in humans.

Gregory J Morton1, Karl J Kaiyala, Karen E Foster-Schubert, David E Cummings, Michael W Schwartz.   

Abstract

CONTEXT: Fibroblast growth factor 19 (FGF19) improves glycemic control in diabetic animals and is secreted from the gastrointestinal tract after meals in response to bile acid stimulation.
OBJECTIVE: We sought to understand how ingestion of carbohydrates, protein or lipids affect both FGF19 and bile acid concentrations in human plasma, with the hypothesis that variation in the bile acid response to different macronutrients would predict differences in plasma FGF19 levels.
DESIGN: This was a randomized, within-subjects crossover study.
SETTING: The study was conducted at a university clinical research center. PARTICIPANTS: There were 16 healthy human subjects included in the study.
INTERVENTIONS: Isocaloric, isovolemic beverages composed primarily of carbohydrates, proteins, or lipids were provided to each participant on 3 separate occasions. MAIN OUTCOME MEASURES: The magnitudes of postprandial rises of plasma FGF19 and total bile acid levels were determined.
RESULTS: All beverages induced an initial transient decline of plasma FGF19 levels during the first 60 minutes after consumption. For FGF19, the ingestion of carbohydrate was associated with the fastest and highest increase of plasma levels, returning to baseline at 5 hours. By comparison, the protein beverage induced a modest but significant elevation of FGF19 levels that peaked at the end of the 6-hour sampling interval, whereas a lipid beverage was without effect. In contrast, total bile acid levels increased in plasma only in response to a high-lipid beverage, demonstrating a marked divergence between the FGF19 and bile acid response to lipid vs carbohydrate.
CONCLUSIONS: A bile acid-independent mechanism is implicated in the effect of meals to raise plasma FGF19 concentrations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297792      PMCID: PMC3913810          DOI: 10.1210/jc.2013-3129

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

Authors:  T Lundåsen; C Gälman; B Angelin; M Rudling
Journal:  J Intern Med       Date:  2006-12       Impact factor: 8.989

Review 2.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

3.  Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.

Authors:  Kwang-Hoon Song; Tiangang Li; Erika Owsley; Stephen Strom; John Y L Chiang
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

4.  Gallbladder responses to modified sham feeding: effects of the composition of a meal.

Authors:  B J Witteman; M C Jebbink; W P Hopman; A M Masclee; C B Lamers; J B Jansen
Journal:  J Hepatol       Date:  1993-11       Impact factor: 25.083

Review 5.  Role of bile acids and bile acid receptors in metabolic regulation.

Authors:  Philippe Lefebvre; Bertrand Cariou; Fleur Lien; Folkert Kuipers; Bart Staels
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

6.  Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates.

Authors:  Karen E Foster-Schubert; Joost Overduin; Catherine E Prudom; Jianhua Liu; Holly S Callahan; Bruce D Gaylinn; Michael O Thorner; David E Cummings
Journal:  J Clin Endocrinol Metab       Date:  2008-01-15       Impact factor: 5.958

Review 7.  The FGF family: biology, pathophysiology and therapy.

Authors:  Andrew Beenken; Moosa Mohammadi
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

8.  The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin.

Authors:  R E Roberts; C Glicksman; J Alaghband-Zadeh; R A Sherwood; N Akuji; C W le Roux
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

9.  FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway.

Authors:  Matthew J Potthoff; Jamie Boney-Montoya; Mihwa Choi; Tianteng He; Nishanth E Sunny; Santhosh Satapati; Kelly Suino-Powell; H Eric Xu; Robert D Gerard; Brian N Finck; Shawn C Burgess; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2011-06-08       Impact factor: 27.287

10.  FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.

Authors:  Serkan Kir; Sara A Beddow; Varman T Samuel; Paul Miller; Stephen F Previs; Kelly Suino-Powell; H Eric Xu; Gerald I Shulman; Steven A Kliewer; David J Mangelsdorf
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

View more
  11 in total

Review 1.  Fibroblast growth factors 19 and 21 in acute liver damage.

Authors:  Zhao Shan; Gloria Alvarez-Sola; Iker Uriarte; María Arechederra; Maite G Fernández-Barrena; Carmen Berasain; Cynthia Ju; Matías A Avila
Journal:  Ann Transl Med       Date:  2018-06

2.  Roux-en-Y Gastric Bypass Surgery Has Unique Effects on Postprandial FGF21 but Not FGF19 Secretion.

Authors:  Lydia-Ann L S Harris; Gordon I Smith; Bettina Mittendorfer; J Christopher Eagon; Adewole L Okunade; Bruce W Patterson; Samuel Klein
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

3.  Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease.

Authors:  Arno R Bourgonje; Laura A Bolte; Lianne L C Vranckx; Lieke M Spekhorst; Ranko Gacesa; Shixian Hu; Hendrik M van Dullemen; Marijn C Visschedijk; Eleonora A M Festen; Janneke N Samsom; Gerard Dijkstra; Rinse K Weersma; Marjo J E Campmans-Kuijpers
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

4.  Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.

Authors:  J M Gallego-Escuredo; J Gómez-Ambrosi; V Catalan; P Domingo; M Giralt; G Frühbeck; F Villarroya
Journal:  Int J Obes (Lond)       Date:  2014-05-12       Impact factor: 5.095

5.  FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.

Authors:  Saachi Sachdev; Qi Wang; Charles Billington; John Connett; Leaque Ahmed; William Inabnet; Streamson Chua; Sayeed Ikramuddin; Judith Korner
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

6.  Circulating bile acids in healthy adults respond differently to a dietary pattern characterized by whole grains, legumes and fruits and vegetables compared to a diet high in refined grains and added sugars: A randomized, controlled, crossover feeding study.

Authors:  Bigina N R Ginos; Sandi L Navarro; Yvonne Schwarz; Haiwei Gu; Dongfang Wang; Timothy W Randolph; Ali Shojaie; Meredith A J Hullar; Paul D Lampe; Mario Kratz; Marian L Neuhouser; Daniel Raftery; Johanna W Lampe
Journal:  Metabolism       Date:  2018-02-17       Impact factor: 8.694

Review 7.  Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System.

Authors:  Kim L Mertens; Andries Kalsbeek; Maarten R Soeters; Hannah M Eggink
Journal:  Front Neurosci       Date:  2017-11-07       Impact factor: 4.677

Review 8.  The Brain-Gut-Microbiome Axis.

Authors:  Clair R Martin; Vadim Osadchiy; Amir Kalani; Emeran A Mayer
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-04-12

9.  Plasma and Urinary Amino Acid-Derived Catabolites as Potential Biomarkers of Protein and Amino Acid Deficiency in Rats.

Authors:  Joanna Moro; Nadezda Khodorova; Daniel Tomé; Claire Gaudichon; Catherine Tardivel; Thierry Berton; Jean-Charles Martin; Dalila Azzout-Marniche; Delphine Jouan-Rimbaud Bouveresse
Journal:  Nutrients       Date:  2021-05-07       Impact factor: 5.717

Review 10.  Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review.

Authors:  G Abdeen; C W le Roux
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.